Early Diagnosis Improves Clinical Outcomes in PsA Early Diagnosis Improves Clinical Outcomes in PsA
Psoriatic arthritis diagnosis by a rheumatologist within a year of symptom onset improved long-term clinical outcomes, a study showed.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 18, 2024 Category: Rheumatology Tags: Rheumatology Source Type: news

Rheumatology Workforce Increased 20 Percent From 2009 to 2019
THURSDAY, March 14, 2024 -- The overall number of clinically active rheumatology providers grew more than 20 percent during the last decade, according to a study published online Feb. 25 in Arthritis& Rheumatology.Melissa L. Mannion,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2024 Category: Pharmaceuticals Source Type: news

Why Is MoonLake Immunotherapeutics Stock Trading Higher Today?
On Sunday, MoonLake Immunotherapeutics MLTX announced that continued treatment with Nanobody sonelokimab led to significant improvements across all key outcomes at 24-week data from the ARGO trial in psoriatic arthritis (PsA). The 207-patient ARGO trial demonstrated that the primary endpoint, the…#pasi #abbvieincs #abbvhumira #acr50pasi100 #acr #mda #tnf #moonlake (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news

August 2, 2017: Meeting of the Arthritis Advisory Committee Meeting Announcement - 08/01/2017
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

UPDATED PUBLIC PARTICIPATION INFORMATION: August 3, 2017: Meeting of the Arthritis Advisory Committee Meeting Announcement - 08/02/2017
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

COVID-19 Tied to Increased Risk for Rheumatic Disease
(MedPage Today) -- Rates of new-onset autoimmune inflammatory rheumatic disease (AIRD) such as rheumatoid arthritis and systemic lupus erythematosus were significantly increased following bouts of COVID-19 in South Korea and Japan, researchers... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - March 4, 2024 Category: Infectious Diseases Source Type: news

'I'm a pharmacist - stick to this one diet to ease painful arthritis'
The expert advised cutting out some popular foods from your diet that are known to worsen inflammation. (Source: Daily Express - Health)
Source: Daily Express - Health - March 3, 2024 Category: Consumer Health News Source Type: news

Prevalence of Arthritis in U.S. Adults 18.9 Percent in 2022
FRIDAY, March 1, 2024 -- The age-adjusted prevalence of adults with arthritis was 18.9 percent in 2022 in the United States, according to a February data brief published by the National Center for Health Statistics. Nazik Elgaddal, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 1, 2024 Category: Pharmaceuticals Source Type: news

Calcium Crystals in Knee Could Be Worsening Arthritis
FRIDAY, March 1, 2024 -- Once considered harmless by doctors, calcium crystal deposits in the knee joint actually can contribute to worsening arthritis, a new study warns.CT scans have revealed that calcium crystals in the knee can promote joint... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2024 Category: General Medicine Source Type: news

ECR: Communication key to better imaging of elderly patients
Imaging elderly patients presents unique challenges, but radiologists can be proactive in making procedures for this population easier, according to a talk given at ECR 2024. In his presentation, Uffe LW Jakobsen from UCL University College in Odense, Denmark, outlined strategies for radiologists to better communicate with elderly patients by treating them like any other patient and forming relationships with them. “Only then can communicate and conduct an examination where we take the appropriate considerations into account without depriving them of their independence and without compromising image quality,” Jakobse...
Source: AuntMinnie.com Headlines - February 29, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Practice Management Source Type: news

'I’m a doctor - here is what your hands can tell you about your health'
Serious health issues such as diabetes, arthritis and heart defects could be detected in the hands. (Source: Daily Express - Health)
Source: Daily Express - Health - February 28, 2024 Category: Consumer Health News Source Type: news

ALOX5 drives the pyroptosis of CD4+ T cells and tissue inflammation in rheumatoid arthritis | Science Signaling
Leukotriene-induced T cell pyroptosis drives synovial inflammation in rheumatoid arthritis. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - February 27, 2024 Category: Science Source Type: news

Why Is Teva Pharma Stock Trading Higher Today?
Friday, Alvotech ALVO and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd TEVA, announced the FDA approved Simlandi (adalimumab-ryvk) injection, as an interchangeable biosimilar to AbbVie Inc’s ABBV Humira. The biosimilar is indicated for adult rheumatoid arthritis,…#alvotech #tevapharmaceuticals #fda #abbvieincs #abbvhumira #crohn #humira #teva #tevapharma #splitspeculations (Source: Reuters: Health)
Source: Reuters: Health - February 26, 2024 Category: Consumer Health News Source Type: news

Woman who suffered excruciating arthritis says 'fantastic' supplement ‘changed her life’
A woman's painful arthritis symptoms were made better after just one box of the supplement. (Source: Daily Express - Health)
Source: Daily Express - Health - February 26, 2024 Category: Consumer Health News Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news